Name | EVRAZIYSKIY MEDITSINSKIY TSENTR, OOO |
---|
INN | 7729426449 |
---|
KPP | 770601001 |
---|
OGRN | 1037729009801 |
---|
OKPO | 14602493 |
---|
Address | 119017, G.moskva, per. Malyy Tolmachevskiy, d. D.8/11 |
---|
Phone | 959-46-31 Contact details |
|
OKVED code | Type | Name of activity type |
---|
86.10 | Core activity | Hospitals | 64.99.11 | Additional activity | Vlozheniya v tsennye bumagi | 64.99.3 | Additional activity | Investments in capital, venture capital investment, including through the investment companies | All types of activities | 68.10 | Additional activity | Buying and selling of own real estate, buildings and dwellings | 68.20 | Additional activity | Renting and operating of own or leased land, buildings and dwellings | 70.10.1 | Additional activity | Management activities of holding companies | 70.10.2 | Additional activity | Activity in holding companies management | 70.22 | Additional activity | Advice on business and management | 73.11 | Additional activity | Activities of advertising agencies | 73.20.1 | Additional activity | Market and opinion research | 86.90.1 | Additional activity | Practices of psychological psychotherapists and therapists | 86.90.9 | Additional activity | Other independent activities in health care | 88.10 | Additional activity | Social care for older people and disabled |
Registration date | 09.04.2003 |
---|
Registering department | Inspektsiya Ministerstva Rossiyskoy Federatsii po nalogam i sboram N29 po Zapadnomu administrativnomu okrugu g.Moskvy |
---|
|
EVRAZMEDTSENTR, OOO (Moscow; INN 7729426449) was registered on 9 Apr 2003. The company's authorized capital as of July 1, 2012 was 13316 rub. Type of ownership of EVRAZMEDTSENTR, OOO - Limited liability companies. Form of ownership of EVRAZMEDTSENTR, OOO - Private property. Principal activities of EVRAZMEDTSENTR, OOO: hospitals (86.10), vlozheniya v tsennye bumagi (64.99.11), investments in capital, venture capital investment, including through the investment companies (64.99.3). |
Economic indicators2023
Net profit (RAS) of EVRAZMEDTSENTR, OOO dropped in 2023 by 48.19% to 64.07 million RUB from 123.68 million RUB over the same period in 2022, the company informed. Revenue decreased in the accounting period by 12.37% to 393.61 million RUB from 449.18 million RUB in 2022; cost of goods sold remained at the same level amounting to 290.20 million RUB compared to 288.82 million RUB; sales profit fell by 48.05% to 64.55 million RUB from 124.25 million RUB. 2022
Net profit (RAS) of EVRAZMEDTSENTR, OOO dropped in 2022 by 35.91% to 123.68 million RUB from 192.97 million RUB over the same period in 2021, the company informed. Revenue decreased in the accounting period by 12.27% to 449.18 million RUB from 512.00 million RUB in 2021; cost of goods sold remained at the same level amounting to 288.82 million RUB compared to 289.64 million RUB; sales profit fell by 35.20% to 124.25 million RUB from 191.73 million RUB. 2020
Net profit (RAS) of EVRAZMEDTSENTR, OOO dropped in 2020 2.00 times to 125.06 million RUB from 250.53 million RUB over the same period in 2019, the company informed. Revenue decreased in the accounting period by 19.23% to 404.93 million RUB from 501.35 million RUB in 2019; cost of goods sold grew by 11.91% to 252.93 million RUB from 226.02 million RUB; sales profit fell 2.00 times to 122.86 million RUB from 245.93 million RUB. 2019
Net profit (RAS) of EVRAZMEDTSENTR, OOO grew over 2019 by 20.16% to 250.53 million RUB from 208.50 million RUB over 2018, the company informed. Revenue increased in the accounting period by 19.03% to 501.35 million RUB from 421.21 million RUB over 2018; cost of goods sold grew by 18.92% to 226.02 million RUB from 190.06 million RUB; sales profit went up by 21.16% to 245.93 million RUB from 202.97 million RUB. 2018
Net profit (RAS) of EVRAZMEDTSENTR, OOO grew over 2018 by 32.31% to 208.50 million RUB from 157.58 million RUB over 2017, the company informed. Revenue increased in the accounting period by 20.20% to 421.21 million RUB from 350.42 million RUB over 2017; cost of goods sold grew by 16.46% to 190.06 million RUB from 163.20 million RUB; sales profit went up by 28.44% to 202.97 million RUB from 158.03 million RUB. 2017
Net profit (RAS) of EVRAZMEDTSENTR, OOO grew over 2017 4.52 times to 157.58 million RUB from 34.86 million RUB over 2016, the company informed. Revenue increased in the accounting period 1.88 times to 350.42 million RUB from 186.41 million RUB over 2016; cost of goods sold grew by 27.73% to 163.20 million RUB from 127.77 million RUB; sales profit went up 4.14 times to 158.03 million RUB from 38.13 million RUB. 2016
Net profit (RAS) of EVRAZMEDTSENTR, OOO dropped in 2016 by 13.87% to 34.86 million RUB from 40.47 million RUB over the same period in 2015, the company informed. Revenue increased in the accounting period by 10.19% to 186.41 million RUB from 169.18 million RUB over 2015; cost of goods sold grew by 15.70% to 127.77 million RUB from 110.42 million RUB; sales profit fell by 7.98% to 38.13 million RUB from 41.44 million RUB. 2014
Net profit (RAS) of EVRAZMEDTSENTR, OOO made up 42.11 million RUB over 2014 compared to net loss of 288.00 thousand RUB over 2013, the company informed. Revenue increased in the accounting period by 32.32% to 182.71 million RUB from 138.09 million RUB over 2013; cost of goods sold decreased by 1.39% to 119.12 million RUB from 120.80 million RUB; sales profit went up 198.39 times to 42.65 million RUB from 215.00 thousand RUB. 2013
Net loss (RA) of EVRAZMEDTSENTR, OOO made up 287.00 thousand RUB over 2013 compared to net profit of 7.04 million RUB over 2012, the company informed. Revenue increased in the accounting period by 23.83% to 138.09 million RUB from 111.51 million RUB over 2012; cost of goods sold grew by 32.12% to 137.87 million RUB from 104.35 million RUB; sales profit fell 33.17 times to 216.00 thousand RUB from 7.17 million RUB. 2012
Net profit (RAS) of Evrazmedcentr, OOO made up 7.04 million RUB over 2012 compared to net loss of 14.95 million RUB over 2011, the company informed. Cost of goods sold grew 6.97 times to 88.41 million RUB from 12.69 million RUB; sales profit made up 7.17 million RUB compared to sales loss of 14.55 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|